The Effect of Bone Morphogenetic Protein 2 (BMP-2)/Estrogen Composite Nanoparticles on the Differentiation Function of Osteoporotic Bone Marrow Mesenchymal Stem Cells (BMSCs)

The menopausal hormone abnormal changes such as estrogen deficiency and increased FSH secretion in female patients in old age may cause osteoporosis which is plagued by patients. The pathogenesis of osteoporosis is not yet fully understood. BMP in the transforming growth factor-β superfamily is a key member in the process of bone growth and development, among which BMP-2 exerts critical roles. Impaired osteogenic differentiation of bone marrow mesenchymal stem cells (BMSC) contributes to the progress of osteoporosis. BMSC plays an indispensable role in treating osteoporosis and can develop into different directions through induction. As the regenerative medicine nanotechnology has become a new medical method, it is believed that BMSC can be used to treat osteoporosis and other related diseases. Our study analyzed the effects of BMP-2/estrogen composite nanoparticles on the proliferation and differentiation of osteoporotic BMSC cells to provide a reliable reference for the future treatment. Our results showed that BMP-2/estrogen composite nanoparticles promoted BMSC cell proliferation, increased ALP activity, decreased apoptosis rate, increased the expression of Col-1, Runx2 and Osterix, upregulated the osteogenic marker BMP-2. As confirmed by Alizarin Red staining, it could differentiate into osteoblasts and the content of Trap was decreased. In conclusion, our study confirms that BMP-2/estrogen composite nanoparticles can promote BMSC cell proliferation, osteogenic differentiation, and inhibit osteoclast differentiation, thereby providing new treatments and theoretical reference basis for treating osteoporosis.

Targeted specific inhibition of bacterial and Candida species by mesoporous Ag/Sn–SnO2 composite nanoparticles: in silico and in vitro investigation

Mesoporous Ag/Sn–SnO2 composite nanoparticles exhibits extraordinary inhibitory properties by targeting different proteins of bacteria and Candida species which can be used to eliminate the resistance of traditional antibiotics.

Nanoparticle Tracers in Reservoir-On-A-chip by Surface-Enhanced Raman Scattering - Fluorescence SERS-SEF Imaging Technology

Nanoparticles or nanocomposite fluids are injected into oil reservoirs for reservoir tracing or to improve injectivity or recovery of oil. Effective application of nanoparticles in fluid flooding still needs to be investigated. Dual-mode surface-enhanced Raman scattering (SERS) - surface-enhanced fluorescence (SEF) composite nanoparticles have been developed as nanoparticle reservoir tracers. This presentation discusses their transport and detectability in porous media, providing valuable information for understanding the role of nanoparticles in EOR process. The dual-mode surface-enhanced Raman scattering (SERS) - surface-enhanced fluorescence (SEF) composite nanoparticles are synthesized composed of Ag or Au metal cores, specific dye molecules, and a SiO2 shell materials. To optimize maximum signal enhancement of both phenomena such as SERS and SEF, the distance between core metal nanoparticles and dye molecules are precisely controlled. The synthesized composite nanoparticles barcoded with dye molecules are detectable by both fluorescence and Raman spectroscopies due to the SERS-SEF phenomena. Both fluorescence and Raman microscopic images of dye embedded surfaceenhanced Raman scattering (SERS) surface-enhanced fluorescence (SEF) composite nanoparticles in water phase successfully were collected within microfluidic reservoir-on-a-chip. The reservoir-on-a-chip utilized in this study fabricated based on reservoir rock geometry and coated with calcium carbonate. The synthesized SERS-SEF composite nanoparticles in water solution have been flooded into the microfluidic reservoir-on-a-chip and imaged for probing interfacial behavior of fluids such as liquid-liquid interfaces and studying the behavior of nanoparticles at liquid-rock interfaces. The precise synthesis method to produce the composite nanoparticles has been developed for the embedded dye molecules to generate noticeably enhanced detectability due to the strong SERS phenomenon. In conclusion, SERS-SEF nanoparticles barcoded with the fingerprinted Raman and fluorescence signals can provide a possible pathway toward SERS-SEF nanoprobe as various barcoded tracers to understand fluid behavior in porous media. Composite nanoparticle synthesis and its detection in flow technologies have been developed for visualization of the fluid flow behavior in porous media representing reservoir rock geometry. The results of the high-resolution nanoparticle fluid imaging data in reservoir-on-a-chip can be applied to understand mechanism of nanoparticle fluid assisted chemical enhanced oil recovery.

O-P03 A composite polymeric nanoparticle as a sensitiser for sonodynamic therapy (SDT)-based treatment of pancreatic cancer

Background Pancreatic cancer remains one of the most recalcitrant forms of cancer with poor prognosis and limited treatment options. SDT is a novel, targeted approach to the treatment of solid tumours. Based on the generation of cytotoxic reactive oxygen species (ROS) following the exposure of a sonosensitiser to ultrasound, the approach is designed to extracorporeally target less accessible lesions. Here we describe the production of a poly(lactic-co-glycolic acid) (PLGA), polyethyleneimine (PEI), Rose Bengal (RB) and indocyanine green (ICG) containing composite nanoparticles and describe their use in SDT-mediated treatment of pancreatic cancer using both in vitro and in vivo target models. Methods Nanoparticles were prepared using an oil in water emulsion and solvent diffusion-based approach. These were designated RB-ICGNP. In vitro SDT treatment consisted of exposing BxPC3 (human PDAC cells), T110029 (murine PDAC cells) or hPSC (immortalised human pancreatic stellate cells) to RB-ICGNP and subsequently treating with ultrasound for 30 s at a frequency of 1 MHz, a power density of 3.0 W/cm2 (SATP) using a duty cycle of 50% at a pulse repetition frequency of 100 Hz. For in vivo studies, BxPC3 (xenograft) and T110029 (syngeneic) tumours were treated with a power density of 3.5 W/cm2 ultrasound for 3.5 min. Results Conclusions Using in vitro and in vivo (human xenograft and murine syngeneic) models of pancreatic cancer, RB-ICGNP composite nanoparticles may be employed as a sensitiser for SDT-based treatment of pancreatic cancer. Since pancreatic stellate cells were more sensitive to SDT, the latter may have an impact on tumour stroma. Staining of residual tumour tissues from SDT-treated animals for connective tissue (stroma) confirmed the latter. Since tumour stroma presents a significant challenge to treatment of pancreatic cancer and represents a negative prognostic marker, the impact delivered by SDT may be exploited to potentiate alternative therapeutic approaches.